UPTIZMA

What this means for you

This application is over — abandoned 11 Jan 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

88705137

Mark type

Stylized text

Filed

25 Nov 2019

Published for opposition

17 Nov 2020

Abandoned

11 Jan 2021

Attorney of record

Monica Riva Talley

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceuticals for reducing side effects and improving efficacy in treatments for cancer and oncology patients; pharmaceuticals for the prevention, treatment and management of superoxide mediated conditions; biotechnological preparations for medical use being biological preparations for the treatment of cancer, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, and radiation protection

Owner

• Galera Therapeutics, Inc., Malvern, PA, US
• Galera Therapeutics, Inc., Malvern, PA, US

Prosecution history

• 11 Jan 2021 — ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
• 11 Jan 2021 — ABANDONMENT - AFTER PUBLICATION
• 07 Jan 2021 — TEAS EXPRESS ABANDONMENT RECEIVED
• 17 Nov 2020 — EXTENSION OF TIME TO OPPOSE RECEIVED
• 17 Nov 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 17 Nov 2020 — PUBLISHED FOR OPPOSITION
• 28 Oct 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 15 Oct 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 15 Oct 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 15 Oct 2020 — EXAMINERS AMENDMENT E-MAILED
• 15 Oct 2020 — EXAMINERS AMENDMENT -WRITTEN
• 01 Oct 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 01 Oct 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 01 Oct 2020 — ASSIGNED TO LIE
• 27 Aug 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED